Abstract In breast tumors the expression of estrogen receptor alpha (ERa) is known to be associated with a more favorable prognosis. ERa expression has been reported to reduce the metastatic potential of breast cancer cells. Recently, we have observed that extracellular matrix proteins activate ERa and that both liganded and unliganded receptor modulate cell invasiveness acting at nuclear level. To explain the mechanisms by which ERa regulates cell adhesion, we have evaluated the expression of a 5 b 1 integrin, prevalently expressed in stationary cells, in response to 17b-estradiol (E2). Here we show that E2/ERa increases the expression of integrin a 5 b 1 through Sp1-mediated binding to a GC-rich region located upstream of an ERE half-site in the 5 0 flanking region of the a 5 gene forming a ternary ERa-Sp1-DNA complex. Estrogen responsiveness of the a 5 gene promoter, as observed in HeLa cells, underlies a general mechanism of regulation which is not strictly linked to the cell type. Our data reveal novel insight into the molecular mechanisms sustaining the reduced invasiveness of ERa expressing cells demonstrating that a 5 b 1 integrin expression is related to the maintenance of the stationary status of the cells, counteracting E2/ERa capability to enhance breast cancer cell migration and invasion.
Introduction
In the mammary gland estrogen receptor alpha (ERa) functions as a hormone-dependent transcription factor regulating the expression of proto-oncogenes which control cell growth and differentiation [1] [2] [3] [4] [5] .
In breast cancer, however, the stimulatory effect of 17b-estradiol (E2)/ERa signaling on tumor cell growth strongly correlates with a lower invasiveness and reduced metastatic potential [6] [7] [8] . For instance, previous studies and our recent findings demonstrate how the exposure of breast cancer cells to extracellular matrix (ECM) proteins increases cell proliferation [9] , enhances functional transactivation of ERa, and reduces cell invasiveness in ERapositive (ER?) breast cancer cells [10] .
On the other hand, it is well documented how E2/ERa up-regulates genes which reduce cell invasiveness like a-1-antichymotrypsin [11] and down-regulates genes involved in the enzymatic remodeling and degradation of ECM proteins like metalloproteinase-9 [12] and Collagenase type IV [13] .
Cell adhesion to ECM is mainly mediated by integrins which mostly control the physical strength of cell substratum attachment [14] . Several studies have demonstrated that variations in cell surface expression levels of integrin [15] , or in adsorbed concentration of its substratum, or its ligand [16] , or in the integrin-ligand affinity [17] , could affect the adhesion strength and the speed of cell movement [14] .
A role for E2/ERa in integrin expression derives from physiological circumstances consistent with evidence indicating that a 5 b 1 levels double in breast tissues between Diego Sisci and Emilia Middea contributed equally to this study. puberty and sexual maturity and drop dramatically after ovariectomy [9] . So, E2 seems to exert a specific modulatory role on integrin expression which mostly regulates the adhesion of tumor cells to substrates.
Fibronectin (Fn)-mediated attachment and signaling in cells occurs in response to Fn-binding to cell surface integrins. Fn has been demonstrated to bind to different Fn-specific integrins including a 4 b 1 , a 5 b 1 , a v b 1 , a v b 3 , and a v b 6 [18] . However previous studies have shown that the a 4 subunit is not present in mammary cells [19] . Furthermore immunohistochemical analyses revealed little or no av protein in mammary epithelia or in myoepithelial cells [20] at any stage of development examined. Other authors have reported that the a 5 is the key receptor subunit for Fn and that a 5 knockout mice most closely resemble Fn knockout mice [18, 21] .
On the basis of these findings we reasonably focused our attention on the effects of E2 on the a 5 integrin subunit being this subunit fully representative of the a 5 b 1 integrin expression.
In this study we elucidated the molecular mechanism by which E2/ERa signaling up-regulates the expression of the a 5 integrin subunit either in MCF-7 or HeLa cells ectopically expressing ERa. This event appears to occur through the formation of a trascriptionally active ERa-Sp1 complex that binds to the GC-rich (Sp1) (-420 to -370) region located upstream of ATG and very likely indicates a general modulatory mechanism induced by E2 which is not tightly linked to the cell type investigated.
Materials and methods

Cell lines and cell culture conditions
Two ER? human breast cancer epithelial cell lines, MCF-7 and T47D and an ERa-negative (ER-) cervicae carcinoma cell line HeLa were used. MCF-7 and T47D cells were maintained in monolayer culture in Dulbecco's modified Eagle's/Ham's F-12 medium (1:1) (DMEM/F12; Gibco, USA) supplemented with 5% calf serum (CS; Eurobio, F), 100 UI/ml penicillin (Eurobio, F), 100 ug/ml streptomycin (Eurobio, F), and 0.2 mM L-glutamine (Eurobio, F). HeLa cells were maintained in monolayer cultures in Minimal Essential Medium with Erlie's salts (MEM; Gibco, USA) supplemented with 10% fetal bovine serum (Eurobio, F), 100 UI/ml penicillin, 100 ug/ml streptomycin, and 0.2 mM L-glutamine. Cells were passaged weekly using trypsin-EDTA (Eurobio, F) and media were changed every 2 days. Both cell lines were cultured at 37°C in 5% CO 2 in a humidified atmosphere.
In all experiments, steroids and growth factors were deprived from cells growing them in serum-and phenol red-free DMEM/F12 (SFM; Gibco, USA) containing 0.5% BSA and 2 mM L-glutamine for 24 h.
Fluorescence-activated cell sorting
Serum-starved MCF-7 cells were treated with 10 nM E2 for 4, 12, and 24 h or for 24 h with increasing concentration of E2 (1, 10, 100 nM). Cells were detached with EDTA solution (Versene), washed and incubated with anti-integrin a5 antibody (H-104, Santa Cruz Biotechnology, USA) or anti-integrin a4 antibody (7.2, Santa Cruz Biotechnology, USA) for 1 h at 22°C. Cells were then washed twice in PBS and incubated with a fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Santa Cruz Biotechnology, USA) for 1 h at 37°C. After two washes in PBS, cells were fixed with 70% ethanol and subjected to Fluorescenceactivated cell sorting (FACS) analysis. At least 1 9 10 4 cells were measured in a FACS flow cytometer (Becton Dickinson, USA). MCF-10 cells were used as control.
Western blotting
To evaluate the influence of E2 on a 5 protein expression, MCF-7 and T47D cells, serum-starved for 24 h, were incubated with 10 nM E2 (Sigma Aldrich, USA) for 16, 24, and 48 h. In some experiments the cells were treated with 1 lM of the E2 antagonist ICI 182,780 (ICI; Zeneca, UK). At the end of each incubation time, cells were washed with ice-cold PBS and lysed for 1 min at 4°C in Triton lysis buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM CaCl 2 , 1% Triton X-100, 0.2 mM Na 3 VO 4 , 1% PMSF, 1% Aprotinin). Cell lysates were cleared by centrifugation (14000 rpm for 10 min at 4°C) and the protein content was determined using Bradford Dye Reagent (Bio Rad, USA) according to manufacturer's instructions. Cellular lysates (10-30 lg of protein/lane) were resolved by SDS-PAGE, transferred to nitrocellulose membranes and probed with either anti-a 5 integrin polyclonal antibody (H-104, Santa Cruz Biotechnology, USA) or anti-GAPDH polyclonal antibody (FL-335, Santa Cruz Biotechnology, USA). The antigen-antibody complexes were detected by incubation of the membranes with peroxidase-coupled anti-rabbit IgG and developed using the ECL Plus Western Blotting detection system (Amersham Pharmacia Biotech, UK).
RT-PCR
MCF-7 and T47D cells were incubated for 24 h in SFM and then treated with E2 10 nM for 24 h and/or 1 lM ICI 182,780 (ICI; Zeneca, UK). At the end of the treatment total cellular RNA was extracted using RNeasy (Qiagen, USA) and reverse transcribed using Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Promega, USA). Briefly, reverse transcription (RT) was performed using 1 lg of total RNA in a final volume of 10 ll by incubation at 37°C for 30 min with 200 U of M-MLV reverse transcriptase, 0.4 lg oligo dT, 0.5 lM deoxynucleotidetriphosphate (dNTP) and 24U RNAsin (Promega, USA), followed by heat denaturation for 5 min at 95°C. Subsequent PCR analysis was performed on 1 ll of the RT product in a final volume of 50 ll. The following pairs of primers were used to amplify the 188 bp of a 5 integrin: 5 0 -CCCCGCTCGTGCCGCTGCTGTT-3 0 (a 5 forward) and 5 0 -CCCCCACCCCC-ATCCCGTCTCC-3 0 (a 5 reverse). The PCR amplification was performed using 1.25 U GoTaq DNA polymerase (Promega, USA), 19 PCR buffer (10 mM Tris-HCl, 50 mM KCl), 2.5 mM MgCl 2 , 0.2 mM of each dNTP, and 1.5 pM of primers for a 5 or 36B4. PCR conditions were 30 s at 94°C, 40 s at 59°C, and 60 s at 72°C for 30 cycles. PCR products (10 ll) were separated on a 1.0% agarose gel. Amplification of the 408 bp of ribosomal RNA 36B4 was performed as control using the following primers: 5 0 -CTCAACATCTCCCCCTTCTC-3 0 (36B4 forward) and 5 0 -CAAATCCCA-TATCCTCGTCC-3 0 (36B4 reverse).
Plasmid constructs
To create the Luciferase expression vector pGL3-pa 5 encoding the 5 0 -flanking region of the a 5 gene [22] , genomic DNA was extracted from MCF-7 by TRIzol reagent following the manufacturer's instructions and amplified by PCR using the following primer pairs 5 0 -ACTCCTGGGTT TTCAATACTG-3 0 (forward) and 5 0 -CCCGCTCTTCCCT GTCC-3 0 (reverse). PCR amplification was performed using the same reagents reported above. PCR conditions were 5 min at 95°C followed by 1 min at 94°C, 1 min at 58°C, and 1 min at 72°C for 30 cycles. The obtained fragment was inserted in the pCR 2.1 plasmid using the TA cloning kit (Invitrogen, USA), sequenced, and cut with HindIII and XhoI. The insert was then cloned into the pGL3 basic vector (Promega, USA). The deletion mutant in positions from -424 to -370 of the a 5 gene 5 0 -flanking sequence corresponding to a Sp1/ERE half-site motif (Fig. 4a) was created using PCR (pGL3-pa5-DSp1/ERE). The oligonucleotides used as PCR primers were as follows: 5 0 -ACTCCTGGG TTTTCAATACTG-3 0 (forward), 5 0 -CCTTAAGAG-GAAG CCTGTATATGTGTG-3 0 (reverse) and 5 0 -CGAATTCGA TTCCTTTCCTCATTAGGA-3 0 (forward), 5 0 -CCCGCTC TTCCC-TGTCC-3 0 (reverse). The PCR products were digested with EcoRI (underlined in primers), ligated and inserted in the pCR 2.1 plasmid using the TA cloning kit. The obtained plasmid was digested with HindIII and XhoI. The insert was then cloned into the pGL3 basic vector.
The pGL3-Sp1/ERE plasmid was obtained using two complementary oligonucleotides: 5 0 -ATATGAGCTCCATAT ACAGGCTTCCTCCGCCCACCAGAGGTGATTCCTTT CCTCATTAGG-AAGCTTATAT-3 0 and 5 0 -ATATAAG CTTCCTAATGAGGAAAGGAATCACCTCTGGTGGG C-GGAGGAAGCCTGTATATGGAGCT-CATAT-3 0 . Selfannealing was obtained by boiling and cooling down 10 lg of each oligonucleotide for 5 min in water. The insert was digested with SacI and HindIII (underlined in primers) and successively cloned in pGL3 basic vector.
Site mutation of the Sp1 site (-404 to -399) upstream to the half-ERE binding motif was generated using PCR. The oligonucleotides used as PCR primers were as follows:
0 (reverse). PCR products were inserted into the pCR 2.1 plasmid using the TA cloning kit. The obtained plasmid was digested with KpnI and XhoI (underlined in primers). The insert was then cloned into the pGL3 basic vector pGL3-pa5 (-Sp1).
Plasmids, transfections, and ERE-luciferase assay
In addition to the plasmids described above, the following plasmids were used: the SV40 promoter-based pSG5 vector encoding ERa (wild type) pSG5-HeG0 (HeG0, Tora et al. 1989); pCMV-hE241G, an ERa construct deleted in the nuclear localization signal region (NLS) (aa. 250-303) and inserted in the pCMV expression plasmid (E241G; a gift from Song R); and the Renilla reniformis luciferase expression vector pRL-Tk (Promega, USA).
To monitor the transcriptional activation of a 5 by E2, MCF-7 and HeLa cells (5 9 10 4 density) were plated on a 24-well plates, grown in DMEM/F12 to an approximate confluence of 70-80% and then co-transfected with either pGL3-pa5 (encoding for luciferase under the control of the human a 5 promoter) and pRL-Tk (MCF-7 and HeLa) or with pGL3-pa5, HeG0, and pRL-Tk, or pGL3-pa5, E241G, and pRL-Tk (HeLa). Specific deletion and mutations of the pGL3-pa5 plasmid were generated as described above. The effects of each site mutation/deletion were examined in transfection assays in MCF-7 cells. Transfections were carried out using Fugene 6 (Roche, USA). Cells were transfected in growing medium and 6 h after transfection were washed twice with SFM and shifted to SFM for 24 h and then treated for an additional 24 h with 10 nM E 2 and/or 1 lM ICI 182,780 (ICI; Zeneca, UK) and/or 100 nM mithramycin A (Sigma, USA). Where indicated, cells were treated with mithramycin A for 1 h before stimulation with E2.
Firefly luciferase and Renilla reniformis luciferase activities were determined using the Dual-Luciferase Reporter Assay System (Promega, USA) according to the manufacturer's instructions. Firefly luciferase activity was normalized to Renilla reniformis luciferase activity and expressed as relative luciferase units.
To evaluate the effects of ERa activity on a 5 integrin expression HeLa cells were transfected, as above with increasing concentrations of pSG5-HeG0 (1 and 2 lg), as control HeLa cells were transfected with an empty pSG5 vector. Following transfection, cells were serum-starved for 24 h and then treated for 24 h with 10 nM E2.
Knockdown of a 5 b 1 integrin gene expression siRNA was used for effective depletion of a 5 b 1 integrin gene (Santa Cruz Biotech, USA). A scrambled siRNA (Invitrogen, USA) that lacks identity with known gene targets was used as control for nonsequence-specific effects. MCF-7 and T47D cells were trypsinized, transfected in suspension with Lipofectamine 2000 (Invitrogen, USA), as suggested by the manufacturer, and then plated in 6-well plates (3.5 9 10 5 cells per well). Briefly, cells were transfected with 100 pmol siRNAs in 3 ml total growing medium. siRNAs were diluted in 500 ll of SFM without antibiotic; after 5 min lipofectamine 2000 was added to the mix and incubated at room temperature for 20 min. siR-NA-Lipofectamine 2000 complex was then added to the cells and incubated at 37°C for 6 h, switched to fresh growing medium, and further incubated for additional 18 h. Then cells were switched to SFM for other 24 h and treated or not with 10 nM E2 for 24 h before motility analysis. Forty-eight hours of incubation with the siRNAs was chosen based on a time course performed to evaluate the time needed to obtain a knockdown of at least 60% of a 5 integrin content.
Chromatin immunoprecipitation MCF-7 cells were grown in 10-cm plates. Confluent cultures (90%) were shifted to SFM for 24 h and then treated with 10 nM E2 or left untreated in PRF-CT for 2 h. Following treatment, ChIP methodology was performed as described previously (Morelli et al. 2004 ). The precleared chromatin was precipitated with anti-ERa mAb (Santa Cruz, USA) for ERa, anti-Sp1 pAb (Upstate, USA) for Sp1, and anti-Polymerase II pAb (Santa Cruz, USA) for Pol II. A 4-ll volume of each sample was used as template for PCR with specific primers. The following pairs of primers were used to amplify 312 bp of the a5 promoter region containing the Sp1/half-ERE 5 0 -ACC CCAAAGTCTCCTCCCTCCCG-3 0 (forward); 5 0 -CCCGCG TCCCCCACCCCTAAG-3 0 (reverse). The PCR conditions were: 1 min at 94°C, 45 s at 59°C, and 45 s at 72°C. The amplification products obtained in 28 cycles were analyzed in a 2% agarose gel and visualized by ethidium bromide staining.
Gel mobility shift assay Nuclear protein extracts were prepared and collected as reported in DAPA. The probes were generated by annealing single-stranded oligonucleotides (reported below) labeled with [c-32P] ATP and T4 polynucleotide kinase and then purified using Sephadex G50 spin columns. The oligonucleotides used as probes and as cold competitors (synthesized by Sigma Genosys, UK) are listed below. The protein binding reactions were carried out in 20 ll of buffer (20 mM HEPES, pH 8, 1 mM EDTA, 50 mM KCl, 10 mM dithiothreitol, 10% glycerol, 1 mg/ml BSA, 50 lg/ml poly (dI-dC) with 50000 cpm of labeled probe, 20 lg of MCF-7 nuclear protein or 15 ng of Sp1 and 0.18 pmol of purified ERa recombinant proteins (both purchased from Invitrogen, USA), and 5 lg of poly (dI-dC)). The above-mentioned mixture was incubated at room temperature for 20 min in the presence or absence of unlabeled competitor oligonucleotide or specific anti-ERa (anti-ERa F-10) or Sp1 (anti-Sp1 1C6) antibodies, both purchased from Santa Cruz Biotechnology, USA. The entire reaction mixture was electrophoresed through a 6% polyacrylamide gel for 3 h at 150 V. Gel was dried and subjected to autoradiography at -70°C.
Oligonucleotides used (nucleotide motifs of interest are underlined):
DNA affinity precipitation assay DNA affinity precipitation assay was performed as described by Suzuki et al. [23] with minor modifications. Nuclear extracts were prepared from MCF-7 cells. Sub-confluent cultures (70%) were shifted to SFM for 24 h and then treated with 10 nM E2 for 24 h, or left untreated in SFM. Following treatment, cells were scraped in cold PBS, and resuspended in 400 ll of cold buffer A (10 mM HEPES-KOH, pH 7.9, at 4°C, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM PMSF, 1 mM leupeptin). The cells were allowed to swell on ice for 10 min, centrifuged, and the pellet was resuspended in 50 ll of cold Buffer B (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM PMSF, 1 mM leupeptin) and incubated on ice for 20 min for high salt extraction. Cellular debris was removed by centrifugation for 2 min at 4°C, and the supernatant fraction (containing DNA-binding proteins) was stored at -70°C. The yield was determined by Bradford method. The 26-bp probe was prepared by annealing the biotintreated sense oligonucleotide (5 0 -TTCCTCCGCCCAC CAGAGGTGATTCC-3 0 ) and non-biotinated antisense oligonucleotide. A 3-pmol sample of the probe was added to 100 lg of the protein nuclear lysates and placed on ice for 40 min. Then 20 ll of streptavidin-coated beads (Promega) were added and the sample was incubated for a further 3 h at 4°C with rotation. After separation of the beads from the supernatant by centrifugation, the beads were washed five times with binding buffer, suspended with 40 ll of sample buffer, boiled and used for western blotting as a DNA-bound fraction. The supernatant was mixed with an equal volume of 29 sample buffer, boiled and used for western blotting as an unbound fraction. For competition, a 10-fold excess of unlabeled probe was added to the nuclear lysate and incubated on ice for 30 min before addition of the labeled probe.
Motility assay
To evaluate the role of a 5 b 1 integrin on cell motility we performed a knockdown of a 5 b 1 integrin, as reported in ''Plasmids, transfections, and ERE-luciferase assay'' Fig. 1 Cell surface expression of a 5 integrin subunit in response to E2 treatment in MCF-7 cells. a 5 integrin subunit expression was determined by FACS analysis and western blotting. a MCF-7 cells were serum-starved for 24 h, treated with 10 nM E2 for 4, 12, and 24 h, and detached with EDTA solution. Cells were resuspended in PBS and incubated with anti-alpha5 integrin antibody followed by fluorescein-conjugated anti-rabbit IgG. Cells were analyzed in a FACS flow cytometer. The results indicate the percentage of positive cells compared to cells labeled with an isotype matched control antibody; the results are representative of three independent experiments and reported as mean ± SD. Statistical analysis was performed by Student's t-test (* P \ 0.05 versus untreated). b MCF-7 cells serum-starved for 24 h were treated or left untreated with E2 (0, 1, 10, and 100 nM) for 24 h. Cells lysates were subjected to western blotting with an anti-a 5 integrin. GAPDH expression was evaluated as loading control. The graph represents the mean ± SD of the optical density relative increase of a 5 integrin subunit levels with respect to untreated samples that were arbitrarily set at 1. The results are representative of three independent experiments. Statistical analysis was performed by Student's t-test (* P \ 0.05 versus untreated). c Serum-starved MCF-7 cells (i) were incubated or not with E2 (0, 10, and 100 nM) for 24 h, and detached with EDTA solution. Cells were resuspended in PBS and incubated with either an anti-a 5 (white bar) or an anti-a 4 (grey bar) integrin antibody followed by fluorescein-conjugated anti-rabbit or anti-mouse IgG, respectively. Cells were analyzed in a FACS flow cytometer. MCF-10 cells (ii) were used as control. The results indicate the percentage of positive cells compared to cells labeled with an isotype matched control antibody; the results are representative of three independent experiments and reported as mean ± SD. Statistical analysis was performed by Student's t-test (* P \ 0.05 versus untreated) section, in both MCF-7 and T47D cell lines, before motility assays. After transfection, cells were maintained in SFM for 24 h and then treated with E2 for additional 24 h. At the end, cells were dispersed with versene (Eurobio, F), washed twice, resuspended in SFM, counted using a hemocytometer and plated on 24-well modified Boyden chambers containing porous (8 lm) polycarbonate membranes (Costar, USA). For cell invasion experiments the chambers were coated on the internal surface, with 30 lg/ml Fn by incubation at room temperature. The lower chambers were loaded with 500 ll of either SFM for migration assays or SFM containing 5% CS for invasion assays, while synchronized cells (1 9 10 5 ) suspended in 200 ll of SFM with or without 10 nM E2 were plated into the upper chambers. After 8 h of incubation in 5% CO 2 at 37°C, the cells in the upper chamber were removed by a cotton swab, so that only cells that had migrated through the membrane remained. The membranes were then fixed and stained in Coomassie blue solution (0.25 g Coomassie blue, 45 ml water, 45 ml methanol, 10 ml glacial acetic acid) for 5 min, then each well was rinsed three times with distilled water. The migrated cells were counted using an inverted microscope.
Statistical analysis
All data were expressed as the mean ± SD (standard deviation) of at least three independent experiments. Statistical significances were tested using Student's t-test.
Results a 5 Integrin subunit expression in MCF-7 cells upon E2 exposure
The expression of the a 5 integrin subunit in response to E2 stimulation was evaluated in MCF-7 cells. We focused our attention on the a 5 integrin subunit, which is strongly indicative of integrin a 5 b 1 expression, since only the b 1 subunit protein has been demonstrated to form a heterodimer with the a 5 subunit, so the detection of the a 5 subunit has been reported to mean that the a 5 b 1 integrin was also detected herein.
Serum-starved MCF-7 cells were treated with 10 nM E2 for 4, 12, and 24 h before immunodetection of the a 5 integrin subunit by FACS analysis (see ''Materials and methods''). As shown in Fig. 1a , the exposure to E2 induced an increase in a 5 integrin subunit expression that became significant starting from 12 h of treatment. The significant up-regulation of a 5 integrin subunit levels was also observed in serum-starved MCF-7 cells treated for 24 h with increasing concentrations of E2 (1, 10, 100 nM) (Fig. 1b) . The increment of a 5 integrin subunit expression in response to E2 was also observed in T47D cells (data not shown).
To further assess the specificity of E2-dependent a 5 integrin subunit expression, we evaluated whether E2 was also able to regulate a 4 integrin subunit levels, since its expression has been reported to be associated with a reduction of breast cancer cell invasiveness [24] . E2 administration induced a dose-dependent increase of a 5 expression, but did not affect a 4 integrin subunit levels ( Fig. 1c(i) ).
E2 regulates the expression of a 5 integrin subunit
To further investigate the mechanistic basis for the estrogen-dependent regulation of a 5 integrin subunit expression, we carried out a time course analysis. MCF-7 cells were serum-starved for 24 h and then treated with 10 nM E2 for 16, 24, and 48 h. The a 5 integrin subunit expression was detected on protein lysates. As shown in Fig. 2a a marked decrease of a 5 integrin subunit was observed following a prolonged starvation (48 h), while E2 stimulation induced a significant increase of its expression. In addition, E2 induced a dose-dependent increase of a 5 integrin subunit expression (Fig. 2c) . The up-regulation observed was Fig. 2 17b-Estradiol increases the expression of the a 5 integrin subunit in MCF-7 cells. MCF-7 cells serum-starved for 24 h were treated or left untreated with 10 nM E2 for 16, 24, and 48 h (a) and with 1, 10, and 100 nM of E2 and/or 1 lM ICI 182,780 (c). Cells were lysed after incubation, and proteins were subjected to western blotting with an anti-integrin a 5 antibody or an anti-GAPDH as loading control. The results are representative of three independent experiments. The graph represents the mean ± SD of the optical density of a 5 integrin subunit normalized versus GAPDH and represented as relative increase with respect to untreated samples that were arbitrarily set at 1. Data were statistically analyzed by Student's t-test (* P \ 0.05 versus untreated). MCF-7 cells were treated for 24 and 48 h with 10 nM E2 (b) or with 1, 10, and 100 nM E2 and/or 1 mM ICI 182,780 (d) and total RNA was extracted. The abundance of a 5 integrin subunit mRNA was detected by RT-PCR, as described in ''Materials and methods.'' 36B4 mRNA levels were determined as control. The results are representative of three independent experiments. The graph represents the mean ± SD of the optical density of a 5 integrin subunit normalized versus 36B4 and reported as relative increase with respect to untreated samples that were arbitrarily set at 1. Data were statistically analyzed by Student's t-test (* P \ 0.05 versus untreated). e HeLa cells were transfected with increasing amount of pSG5-HeG0 (ERa: 1 and 2 lg) or pSG5 empty vector (Vector). Transfected cells were serum-starved for 24 h and consecutively treated with E2 (10 nM). a 5 integrin and ERa expression was detected by WB. The graph represents the mean ± SD of the optical density relative increase of a 5 integrin subunit levels with respect to untreated samples that were arbitrarily set at 1. The results are representative of three independent experiments. Data were statistically analyzed by Student's t-test (* P \ 0.05 versus untreated) mediated by ER activation since the addition of ICI 182,780 abrogated it (Fig. 2c) .
The observed up-regulation was directly correlated to a significant increase in a 5 integrin mRNA transcription (Fig. 2b, d) .
To demonstrate that the increased expression of the a 5 integrin subunit was specifically mediated by ERa, we transfected HeLa cells with increased amounts of HeG0, treated with E2 (10 nM) for 24 h, and protein lysates were used to detect the a 5 integrin subunit. E2 stimulation increased a 5 integrin expression in ERa content related manner (Fig. 2c) , supporting the conclusion that E2 regulates the expression of To investigate the mechanisms by which E2 regulates a 5 gene expression, we prepared a pGL3-pa5 plasmid containing a construct bearing the 5 0 -flanking region of the a 5 gene [22] obtained by PCR, as described in ''Materials and methods,'' conjugated with a luciferase reporter gene. This region has been previously shown to be active as a promoter in the control of a 5 integrin gene expression [22] .
MCF-7 cells were transfected with the pGL3-pa5 reporter plasmid and exposed to 10 nM E2 and/or 1 lM ICI for 24 h before luciferase assay. Figure 3a shows a significant increase in luciferase expression induced by E2 that is abolished by ICI. The same results were obtained in HeLa cells transfected with HeG0, pGL3-pa5, and pRL-Tk (Fig. 3c) , while E2 failed to induce luciferase activity in HeLa cells transfected with the reporter plasmids alone (Fig. 3b ) and in the same cells transfected with pCMVhE241G, a construct bearing ERa deleted in the nuclear localization signal (NLS), pGL3-pa5, and pRL-Tk (Fig. 3d) . All together, these data indicate the a 5 integrin subunit as an E2/ERa-regulated gene.
ERa and Sp1 bind to the 5
0 -flanking region of a 5 integrin subunit
The 5
0 -flanking region of the a 5 integrin subunit contains several elements located between positions -178 and -27 that are required for efficient basic transcription of the gene, such as AP1 sites [22] , and Sp1 and nuclear factor 1 (NF-1) sites which respond to cell adhesion on Fn [25] . The structural analysis of the a 5 promoter revealed the presence of an half-ERE motif adjacent to a SP1 site which may potentially mediate the response to E2 treatment [26] . Since ERa can activate target promoters either in a classical way, by directly binding to specific ERE sequences, or indirectly, through a functional interaction with other nuclear proteins such as Sp1 and subsequent binding to Sp1 responsive sequences [27] [28] [29] [30] [31] [32] , we assessed the occupancy of the 5 0 -flanking region of the a 5 integrin subunit by ERa and Sp1 in MCF-7 cells using ChIP assay. As illustrated in Fig. 4 , unliganded ERa is associated with the 5 0 -flanking region of the a 5 integrin gene containing the Sp1/half-ERE binding sites and its binding is strongly enhanced by the addition of E2. The binding of ERa to this promoter region is concomitant with the recruitment of Sp1. A small amount of Pol II was found to bind the promoter in untreated cells, reflecting a basal regulation of the a 5 integrin gene expression (Fig. 4) . E2 addition increased the On the basis of ChIP results, we hypothesized that both the half-ERE motif and the SP1 site may be involved in E2 induced a 5 integrin subunit expression. To confirm our hypothesis two reporter plasmids were constructed as described in ''Materials and methods,'' the pGL3-pa5-DSp1/ERE which contains a specific deletion from positions -420 to -370 of the 5 0 -flanking sequence of a 5 gene corresponding to a Sp1/half-ERE motifs (Fig. 5a) , and a pGL3-Sp1/ERE which contains the putative sequence responsible of E2 responsiveness (Fig. 5a) .
As reported in Fig. 5b , the deletion of the Sp1/ERE halfsite motif totally abolished the E2 responsiveness of the promoter. As expected, an increase in luciferase expression was observed in cells transfected with the pGL3-Sp1/ERE construct in response to E2 that was abrogated by ICI (Fig. 5c) , showing that the SP1/half-ERE element is the target for the regulation of the a 5 integrin subunit expression in response to E2.
ERa enhances Sp1 binding to a 5 promoter
The results of our functional assays, which provide evidence for the involvement of the Sp1/half-ERE binding site in mediating the effects of E2 on a 5 integrin expression, fit well with our gel mobility shift assay. Nuclear extracts of MCF-7 cells were incubated in the presence of a 32 P-labeled oligonucleotide reproducing the Sp1/half-ERE motif (Fig. 6a, lane 6) . The protein-DNA complexes formed revealed four slower migrating bands in the untreated nuclear extracts (Fig. 6a, lane 1) which are depleted in the presence of an excess of unlabeled probe (Fig. 6a, lane 2 ) and markedly increased in nuclear extracts obtained from E2-treated cells (Fig. 6a, lane 3) . The specificity of the binding was demonstrated by immunodepletion induced by either anti-ERa (Fig. 6a, lane 4) or anti-Sp1 (Fig. 6a, lane 5) antibodies. Addressing the binding of the bipartite ER-Sp1 complex to the selected Sp1/half-ERE responsive region. To determine whether ERa ''per se'' is able to bind to its own reported half-site and to cooperate with Sp1 binding, gel mobility shift assays were performed using both ERa and Sp1 purified recombinant proteins with the same 32 P-labeled oligonucleotide in a cell-free system (Fig. 6b) . A single gel-shifted band was visible using Sp1 purified protein (Fig. 6b, lane 2) , the specificity of this band was demonstrated using an excess of unlabeled probe that caused a dramatic reduction of the band (Fig. 6b, lane 3) , while the addition of a cold oligonucleotide mutated in the ERE half-site slightly reduced the formation of the protein/ DNA complex (Fig. 6b, lanes 3, 4, respectively) . Unexpectedly, no band was observed incubating the labeled oligonucleotide with ERa purified recombinant protein (Fig. 6b, lanes 5, 6, 7) . It is worth to note that the gelshifted band observed incubating the probe with Sp1 native protein became newly detectable in the presence of increasing amounts of ERa (Fig. 6b, lanes 8-10 ) that resulted drastically reduced using an excess of unlabeled probe (Fig. 6b, lanes 11-13) .
Sp1 is required for E2 regulated expression of the a 5 integrin subunit To explore whether Sp1 contributes to the regulation of a 5 gene expression mediated by ERa, we inhibited the SP1 binding to DNA using mithramycin A, a GC-specific DNA binding drug. As shown in Fig. 7a , mithramycin A treatment caused a significant decrease in luciferase expression of the a 5 promoter construct in response to E2 stimulation in MCF-7 cells.
The requirement of Sp1 recruitment in the regulation of a 5 gene transcription in response to E2 was also confirmed by DAPA (Fig. 7b) . A mutation in the Sp1 site caused a dramatic reduction of ERa binding to a biotinated oligonucleotide bearing the Sp1 consensus sequence and the 5-7) . The presence of shifted complexes was also evaluated by incubating Sp1 (10 ng) with different amounts of the recombinant ERa (0, 0.18, 0.36, and 0.54 pmol). Competition experiments were performed by adding a 100-fold molar excess of either unlabeled probe (lanes 3, 6, 11-13) or the probe mutated in the half-ERE site (reported in ''Materials and methods'') (lanes 4, 7) half-ERE site, while Sp1 binding was completely abrogated (Fig. 7b) .
We confirmed these data using luciferase assays mutating the Sp1 site located at -404 to -399 of the 5 0 -flanking region of a 5 gene (Fig. 7c) . All together our data indicate that the half-ERE motif is not the target of the E2-dependent ER/Sp1 complex, suggesting that the regulation of a 5 gene transcription and expression occurs through a functional interaction of the complex with the Sp1 responsive sequences. Since we have previously demonstrated that ERa expression leads to a lower invasiveness and to a reduced metastatic potential of breast cancer cells through a genomic action [10] , we investigated if a 5 b 1 integrin expression was involved in ERa-mediated reduction of breast cancer cells migration and invasion by knocking down a 5 b 1 integrin (Fig. 8). A knockdown of about 60% of a 5 b 1 integrin expression was obtained after 48 h (Fig. 8a ). In agreement with previous studies [8, 10] , E2 treatment produced a marked and significant reduction of both cell migration (Fig. 8b) and invasion (Fig. 8c) in MCF-7 cells as well as in T47D cells (data not shown). Interestingly, a dramatic increase of both cell migration (Fig. 8b) and invasion ( Fig. 8c) 
Discussion
Previous findings have demonstrated that the concentration of the ECM protein Fn and a 5 b 1 integrin are developmentally and hormonally regulated by steroids in normal mouse mammary glands [9] . The expression of the Fn-specific integrin receptor a 5 b 1 was found to increase between puberty and sexual maturity and to decrease in late pregnancy and lactation, indicating that Fn signaling may be required for mammary gland proliferation in response to ovarian steroids [9] . Breast tumors, which are regulated by ovarian steroids, are usually accompanied by striking Fig. 7 Sp1 is required for the expression of a 5 gene in response to E2. MCF-7 cells (a) were transfected with DNA mixtures containing 0.5 lg pGL3-pa5 reporter plasmid and 50 ng of pRL-Tk. Transfected cells were serum-starved for 24 h and consecutively treated with E2 (10 nM) for 24 h and/or pretreated with Mithramycin A (100 lM). Firefly luciferase activity was internally normalized to Renilla luciferase activity and expressed as fold of increase with respect to untreated samples. Data were statistically analyzed by Student's t-test (* P \ 0.05). The results are expressed as mean ± SD. from several independent experiments. b Nuclear extracts from E2-treated and untreated MCF-7 cells for 24 h were incubated with either a biotinated oligonucleotide containing the Sp1 and the half-ERE binding sites or a biotinated oligonucleotide mutated in the Sp1 consensus site and subjected to DNA affinity precipitation assay as described in ''Materials and methods.'' The specificity of the binding was tested by loading the unbound fraction (C-). E2 treated MCF-7 cells lysate was used as positive control (C?). The results are representative of three independent experiments. c MCF-7 cells were transfected with DNA mixtures containing 0.5 lg pGL3-pa5 reporter plasmid, or the same plasmid mutated in the Sp1 site located at -404/-399 (detailed in ''Materials and methods'') and 50 ng of pRLTk. Transfected cells were serum-starved for 24 h and consecutively treated with E2 (10 nM) for 24 h. Firefly luciferase activity was internally normalized to Renilla luciferase activity and expressed as fold of increase with respect to untreated samples. Data were statistically analyzed by Student's t-test (* P \ 0.05 versus control). The results are expressed as mean ± SD from several independent experiments c changes in ECM components and expression of integrins. While the epithelial basal membrane is intact in normal mammary tissues, it is widely damaged in invasive carcinomas [33, 34] . Particularly, in breast cancers exhibiting major aggressiveness and invasiveness, ERa is no longer expressed. For instance ''in vitro'' invasiveness and motility of ER-breast and ovarian cancer cells appear to be dramatically higher than ER? cells [7, 8, 35] . On the contrary, E2 has been found to enhance breast cancer cell migration and invasion through a rapid and dynamic cytoskeleton rearrangement [36, 37] and a reversible epithelial/mesenchymal-like transition of ER? cells [38] . So, the role of E2 and ERa in breast cancer cell motility and invasion remains still controversial.
We report here for the first time that E2/ERa modulates the expression of a 5 b 1 integrin in breast cancer cells, through the direct activation of the regulatory region of a 5 gene.
Previously we demonstrated how cell adhesion on Fn induces ERa translocation from the cytoplasm into the nucleus increasing the expression of estrogen responsive genes involved in the down-regulation of cell motility and invasion [10] . The increased expression of a 5 integrin in response to E2 stimulation reinforces the evidence that ERa may induce the expression of genes which enhance cell adhesion and reduce cell migration. Some target genes have been described previously, like fibulin-1, a Fn-binding ECM protein [35] that is up-regulated by ERa, metalloproteinase 9 [12] and type IV collagenase [13] whose expression is negatively regulated by ERa.
On the basis of previous finding demonstrating that motile cells express high levels of integrin a 3 b 1 and a v b 1 fibronectin receptor [39] , while stationary cells prevalently express integrin a 5 b 1 [40] , the expression of the latter integrin seems to be a key indicator of the ability of cells to migrate. Indeed, overexpression of a 5 b 1 on the surface of Chinese hamster ovary cells suppresses their transformed phenotype, causing the loss of their ability to grow in soft agar and to form tumors in nude mice [41] . On the contrary, a 5 b 1 integrin has been shown to contribute to the progression of breast cancer. For instance, ligand binding to a 5 b 1 integrin, in the absence of a 4 b 1 , activates invasionstimulatory signals in breast cancer cells [24, 42] .
Virtually little is known about the molecular mechanisms controlling a 5 expression. We demonstrated that the 5 0 -flanking region of the a 5 gene, previously reported to act as a promoter [22] , is a useful tool in the study of the molecular events controlling a 5 gene expression. The 5 0 -flanking region lies within a CpG island, lacks TATA and CCAAT boxes, and contains consensus binding sites for nuclear proteins such as the ets family of protooncogenes, Spl, AP-2, and AP-1 [22] . We have identified a half-ERE site (-393 to -388) located down-stream and in close proximity of a Sp1 binding site (-404 to -399) in the 5 0 -flanking region of the a 5 gene. These adjacent binding sites are crucial effectors of E2 action inducing a 5 gene expression as it emerges from our reporter assay studies. The transcriptional regulation of the a 5 gene was further investigated in HeLa cells ectopically expressing a wild-type ERa and a mutant of the receptor containing a deletion in the nuclear localization signal. The results obtained confirmed estrogen responsiveness of the a 5 gene promoter in HeLa cells expressing ERa but not the deleted mutant, demonstrating how the activation of the a 5 Fig. 8 a 5 b 1 Integrin expression inhibits E2-mediated cell migration and invasion. MCF-7 cells were transfected in suspension with 100 pmol siRNAs/well (sia 5 b 1 integrin or a scrambled siRNA for control samples), plated, starved for 24 h, and treated with E2 (10 nM) for additional 24 h. Cytoplasmic protein extracts (a) (25 lg/ lane) were analyzed by WB to evaluate a 5 b 1 integrin content. GAPDH was evaluated as loading control. The graph represents the mean ± SD of the optical density of a 5 integrin subunit normalized versus GAPDH. MCF-7 cells, transfected and treated as before, were detached, plated and allowed to migrate for 16 h on porous membranes coated (c) or not (b) with 30 lg/ml Fibronectin (Fn) to evaluate the effects of Estradiol (10 nM) exposure on cell motility (b) and invasion (c). Cells were then fixed, stained, and the cells migrated to the lower surfaces of the membranes were counted. The results represent the mean ± SD of three independent experiments. Data were statistically analyzed by Student's t-test (* P \ 0.05 versus untreated; j P \ 0.05 versus the corresponding treatment in scrambled)
promoter by E2/ERa underlines a general mechanism of regulation not tightly linked to the cell type.
Theoretically, E2 regulation of the a 5 gene may be mediated by ERa binding to the 5 0 -regulatory half-ERE motif and/or ERa may interact with Sp1 to transactivate the a 5 gene by binding to the Sp1/half-ERE binding site. Indeed, E2 has been found to activate the transcription of several ERa-regulated genes in a no classical way either through the binding of ERa and the recruitment of Sp1 to their own responsive element separated by 10-23 bases (Sp1(N) [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] ERE half-site) such as c-myc [43] , cathepsin D [44] , retinoic acid receptor a1 [45] , progesterone receptor A [26] , and IRS-1 [46] or through its recruitment on E2-responsive GC-rich promoter motifs by interacting with Sp1 [27] [28] [29] [30] [31] [32] , as reported for epidermal growth factor receptor [47] , progesterone receptor B [48] , cad [32] , and cyclin D1 [49] .
EMSA studies, using oligonucleotides reproducing the Sp1/half-ERE site contained in the 5 0 -flanking region of the a 5 gene, revealed that a 5 gene transcription induced by E2-activated ERa is dependent on GC-rich SP1 binding sites at -404 to -399 in the 5 0 -flanking region of the a 5 gene. Overall, our results suggest that the responsiveness of the a 5 integrin subunit to E2 is mediated by the enhanced binding of the Sp1/ERa complex to the GC-rich Sp1 region and not to the half-ERE site.
The control of a 5 expression by E2 may play an important role in regulating the different biological processes that are dependent on a 5 b 1 integrin-Fn interactions in ERa-positive cells, such as the mechanisms that cells use to detach from and migrate out of the Fn-rich stroma in which they mature.
Generally, a 5 b 1 integrin expression is also related to the maintenance of the differentiated and stationary status of the cells, so we may argue how the expression of a 5 integrin subunit could counteract E2/ERa capability to enhance ''per se'' breast cancer cell migration stimulating the reversible epithelial/mesenchymal-like transition [38] . Indeed the loss of a 5 b 1 integrin expression is concomitant with a dramatic increase of both breast cancer cell motility and invasion upon E2 exposure.
Our data are apparently in contrast to recent data demonstrating how a 4 b 1 integrin antagonizes a 5 b 1 integrin mediated cell invasion in both normal and cancerous mammary cells [24, 42] . The authors reported that activation of a 5 b 1 integrin signals increases cell invasion on type I collagen matrix by up-regulating interstitial collagenase matrix metalloproteinase-1 expression. Since the substratum used in our cell invasion experiments is Fn, it is not surprising that the receptors involved in mediating cell invasion are distinct, and that the increased a 5 b 1 integrin expression enhances cell adhesion on Fn-coated membrane.
Here we demonstrate that in MCF-7 cells, not expressing a 4 b 1 integrin, E2 exposure induces a strong increase of a 5 integrin expression concomitantly with a reduced cell migration as well as cell invasion on Fn. The increased expression of a 5 b 1 integrin in response to E2 treatment appears to be consistent with previously reported observations demonstrating that an increased expression of a 5 b 1 integrin, such as in ERB-B2-positive breast cancer cells, is responsible of the long-term survival of dormant micrometastasis in bone marrow [50, 51] .
On the basis of all these observations, we may conclude that the up-regulatory effects induced by E2 on a 5 b 1 integrin expression may be crucially involved in the regulation of ER? breast cancer cell motility and invasiveness.
